Remedy Pharmaceuticals
New York, US · Delaware corporation · 2 known investors
Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke. It focuses on treatments for serious neurological conditions.
BiotechHealthtech
Founders & leadership
SJ
SVEN JACOBSONExecutive Officer, Director
DG
DAVID GELIEBTERDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$9.1MraisedDec 2015 · 30 investors · PharmaceuticalsRule 506(b)
▶$9.1MraisedDec 2015 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- SVEN JACOBSONExecutive Officer, Director
- DAVID GELIEBTERDirector
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.